Announce Patient Derived Organoid Kit for Tumor Drug Screening2018.11.01

Three-dimensional tissue culture makes the in vitro observation closer to the original environment of the body tissue. Many studies have found that Patient-derived Organoid (PDO) can provide a more similar growth environment, for organ-like observation and drug testing than two- dimensional culture. 

Our company has our own “stent patent” and "PDO culture patent”. This product contains tissue lysis buffer, three-dimensional culture stent (CelluSponge) and cell culture kits. This PDO kit provides complete PDO culture components ,and it can accelerate the proscess of clinical and research application for drug testing and screening.

Product Introduction :